# Peter B. Illei

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-b-illei/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,657 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 63 |
| i10-index | 134 |
| Last Known Institution | Johns Hopkins University |
| OpenAlex ID | https://openalex.org/A5036721299 |
| ORCID iD | 0000-0003-4440-9265 |
| Works | 328 |

## Researcher papers

Showing 12 of 13.

- [Liver from bone marrow in humans](https://scholariq.org/papers/liver-from-bone-marrow-in-humans/)
- [Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer](https://scholariq.org/papers/comprehensive-genomic-analysis-identifies-sox2-as-a-frequently-amplified-gene-in/)
- [Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer](https://scholariq.org/papers/evolution-of-neoantigen-landscape-during-immune-checkpoint-blockade-in-non-small/)
- [Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma](https://scholariq.org/papers/primary-renal-neoplasms-with-the-aspl-tfe3-gene-fusion-of-alveolar-soft-part/)
- [Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)](https://scholariq.org/papers/pathologic-features-of-response-to-neoadjuvant-anti-pd-1-in-resected-non-small/)
- [Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers](https://scholariq.org/papers/transcriptional-programs-of-neoantigen-specific-til-in-anti-pd-1-treated-lung/)
- [A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions](https://scholariq.org/papers/a-distinctive-subset-of-pecomas-harbors-tfe3-gene-fusions/)
- [A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma](https://scholariq.org/papers/a-lethally-irradiated-allogeneic-granulocyte-macrophage-colony-stimulating/)
- [A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction](https://scholariq.org/papers/a-live-attenuated-listeria-vaccine-anz-100-and-a-live-attenuated-listeria/)
- [Detection of Transcriptionally Active High-risk HPV in Patients With Head and Neck Squamous Cell Carcinoma as Visualized by a Novel E6/E7 mRNA In Situ Hybridization Method](https://scholariq.org/papers/detection-of-transcriptionally-active-high-risk-hpv-in-patients-with-head-and/)
- [Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and <i>P16/CDKN2A</i> Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction](https://scholariq.org/papers/global-gene-expression-profiling-of-pleural-mesotheliomas-overexpression-of/)
- [Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer](https://scholariq.org/papers/neoadjuvant-nivolumab-plus-ipilimumab-in-resectable-non-small-cell-lung-cancer/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.